As the largest stem cell bank company in Southeast Asia, CRYOCORD has established designated partnerships with several hospitals in Malaysia. This year, CRYOCORD will visit the Taiwan Healthcare Technology Expo, aiming to strengthen technological collaboration with Taiwan and introduce stem cell products to the Malaysian market.

Careyn, the largest elderly care provider in the Netherlands, has recently shown a strong interest in the Asian market, particularly in seeking partnerships in Taiwan for the digitalization of home care and preventive healthcare. During its participation in the 2024 Taiwan Healthcare Technology Expo, Careyn aims to identify user-friendly digital care systems and preventive health products suited for elderly home care, with the goal of enhancing the quality of home healthcare services in the Netherlands.

With the surge in chronic disease cases and the ongoing strain of the pandemic on healthcare resources, South Africa's demand for medical equipment is rapidly increasing. During the COVID-19 pandemic, this need became especially pronounced. South Africa’s leading medical equipment distributor, Thogwa, is visiting Taiwan to seek new partnerships to address the growing demand in the South African market.

With Thailand's push to become a "World Medical Tourism Hub" and growing healthcare needs from an aging population, demand for surgical equipment is surging. Sappaya Siam, a leading Thai distributor with partnerships across Thailand and Myanmar, is visiting Taiwan for the Healthcare Expo, seeking collaborations with Taiwanese companies to expand Thailand's medical equipment market and capture new opportunities.

The prevalence of chronic diseases in Indonesia has led to a growing demand for in vitro diagnostics, driving rapid growth in the country's diagnostic laboratory market. It is expected to maintain an annual growth rate of 7.13% through 2029.

JDA Marketing, Inc. from the Philippines, with strong expertise in medical distribution, will attend the Taiwan Healthcare Expo to seek partners in digital healthcare and medical consumables, creating a bridge for Taiwanese companies into the Philippine market.

Emitac Healthcare Solutions is actively engaging in digital transformation, seeking international partnerships to drive innovations like smart hospitals and AI-assisted diagnostics, bringing new momentum to healthcare services in the Middle East and North Africa (MENA) region.

Malaysia’s biotech market is rapidly advancing, positioning itself at the forefront of cell therapy and exosome technology within ASEAN. Malaysian biotech company ALLCELL (M) SDN BHD will be seeking business opportunities at the Taiwan Healthcare+ Expo, focusing on partnerships in biopharmaceuticals, cell therapy, and exosome therapy, offering highly promising collaboration prospects for Taiwanese companies.

South Africa's push to expand its healthcare industry over the next 3 years has opened doors for potential collaborations with Taiwanese smart healthcare companies. As the African Continental Free Trade Area (AfCFTA) advances, Africa's healthcare technology market has captured the interest of global investors, positioning South Africa as a critical player in the region. Stiegelmeyer Africa, the largest hospital equipment distributor in South Africa, aims to leverage Taiwan's expertise in smart healthcare technologies to elevate the quality of care in the local market.

Sigmed, a leading name in medical and veterinary equipment from Poland, is setting its sights on Taiwan as it explores new opportunities in the medical and veterinary sectors. With the steady rise in pet ownership in Poland, the demand for quality veterinary products is growing, but local resources are struggling to keep up. Sigmed sees Taiwan as a potential partner in addressing this gap and aims to establish new collaborations during the Taiwan Healthcare+ Expo this December.

Tandry recently showcased its latest advancements at the 86th Annual Meeting of the Taiwan Orthopedic Association (TOA), including its variable-angle locking plate system, underscoring Tandry’s commitment to innovation and quality in orthopedics. The event highlighted Tandry’s international expansion efforts and its collaboration with National Yang Ming Chiao Tung University in developing cutting-edge femoral repair technology, further establishing Tandry as a "hidden champion" of Taiwanese innovation.

BriteMED's upcoming wireless 12-lead portable ECG builds upon the first generation's Windows-based portable ECG transmission, offering groundbreaking solutions for telemedicine, rural healthcare, and home care. This next-generation device features Bluetooth 5.0 technology for enhanced cross-platform compatibility, allowing real-time ECG waveform transmission on Windows, iOS, and Android devices. It also provides clinically validated diagnostic support features.
The device utilizes a non-invasive physiological signal acquisition method, making it easy to monitor patients' heart activity, and it can transmit data electronically, facilitating further tracking and diagnosis. In emergencies, it is equipped with defibrillator protection and pacemaker detection functions to ensure safe usage. BriteMED’s wireless 12-lead portable ECG effectively improves the efficiency of cardiovascular disease diagnosis and management.
Amid the rising global prevalence of cardiovascular/heart diseases, BriteMED provides practical solutions in telemedicine and smart healthcare to address current challenges in diagnosing and managing heart conditions, especially in settings like remote medical consultations, rural healthcare, home care, and mobile clinics, both inside and outside traditional hospital environments.

Applied BioCode, multiplex diagnostics company, exhibits at 2024 Taiwan Healthcare+ Expo, showcasing comprehensive and flexible multiplex diagnostics solution, strides forward to gain global diagnostics market.

Applied BioCode’s solution has shown international traction. With premarket clearance FDA 510k and TFDA registrations for Gastrointestinal Pathogen Panel and Respiratory Pathogen Panel in hand, Applied BioCode rapidly increases install bases of its automated molecular system BioCode MDx3000 in North America recently. Based on this very system, Applied BioCode continues to develop Cov-Flu-Plus, Multiplex Fungal Panel, and STI panel plus resistance markers. Applied BioCode aims to boost presence and utility among the top 600 largest reference labs and medical centers in the US, becoming high throughput multiplex diagnostics leader, and collaborates with Taiwan’s high quality healthcare systems.

Taiwan Healthcare Plus expo will kick off on Dec. 5th in Nangang Exhibition Center I, and Applied BioCode has booth on 4th floor M403.

The demand for healthcare technologies and products in the Middle Eastern countries has surged, driven by population growth, medical tourism, and government healthcare policies. As Qatar’s leading medical equipment supplier, Aamal Company is visiting Taiwan to seek innovative technology partners, aiming to introduce smart healthcare technologies to Qatar and address local medical resource shortages.

According to Japan's Ministry of Internal Affairs and Communications, the population aged 65 and over in Japan has reached 36.25 million, accounting for 29.3% of the total population. This marks a historic high as the country continues to face rapid aging.
With the development of an aging society, Japan’s demand for orthopedic medical devices has significantly increased, particularly in areas such as artificial joints and bone filling materials.
HOYA, one of Japan's top 10 medical device manufacturers, sees potential in Taiwan's Asian market. The company is actively seeking partnerships in orthopedic medical devices through the Taiwan Healthcare+ Expo in December, aiming to meet market needs through Taiwan-Japan collaboration.

As the healthcare market in the Middle East in continuously expanding, the United Arab Emirates (UAE) has emerged as a core market due to high demand and growth potential of healthcare. Al Khayyat Investments (AKI), the UAE’s third-largest healthcare distribution, will be visiting Taiwan in December to participate in the Healthcare+ Expo, seeking collaboration opportunities to introduce Taiwan’s innovative healthcare technologies to the Middle East market.

Dr. Linus Pauling, two-time Nobel Prize winner, once said, “The root cause of most human diseases lies in the lack of trace minerals.” This statement has had a profound impact on future generations, highlighting the importance of complete and balanced nutrition for human health. Inspired by this principle, Total Swiss is committed to providing comprehensive and balanced nutrition to promote cellular health. Following the philosophy that "when cells are healthy, people are healthy," Total Swiss actively strives to help people regain health and stay free from disease.

Since 2022, Total Swiss has partnered with DeYen Pharmaceutical, securing exclusive global sales rights for *Hepanamin Capsule*, an indicated therapy for chronic liver disease. In just one year, Total Swiss quickly expanded to over 40 *Hepanamin* pharmacies. This year, Total Swiss has further joined forces with DyterGene Technology to officially enter the field of precision medicine, becoming a health industry group that integrates precision medicine, PIC/S GMP pharmaceutical manufacturing, and nutrition and health products. Total Swiss is dedicated to offering comprehensive and superior health solutions for people both domestically and internationally.

An interdisciplinary team from the Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative artificial intelligence (AI) software system that can turn an ordinary mobile phone into a medical-grade stethoscope, allowing anyone to use a smartphone to detect heart disease symptoms at their fingertips, and subsequently seek immediate medical attention, without the need for other specialised devices. This patented AI technology enables the detection of valvular heart disease, with an estimated accuracy of 81% – a level comparable to a doctor’s assessment using a stethoscope. This invention promotes early detection of valvular heart disease, personalised health management, heart disease screening, the use of telemedicine, and remote disease monitoring.

At the forefront of future healthcare, filled with challenges, VitalSigns Corp introduces the best wireless, precise, real-time, continuous, analytical, and regulatory-compliant solution, addressing the dual challenge of improving healthcare workers' environments and enabling real-time monitoring of patients' vital signs. Through the wearable multifunctional physiological data collection device VSH101 and the physiological information gateway VSG101, we have launched the revolutionary ECG + Vitals™ service. This service provides 24-hour continuous real-time ECG monitoring and instant interpretation, even in ICU settings, bringing comprehensive monitoring to every corner, assisting dedicated healthcare workers in safeguarding every life!